CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 373 enrolled
Drug / intervention
Connex CVSM with Timmy3 moduledevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06056011
NCT06056011N/ACompleted
CompareCT.gov

TIMMY3 80601-2-56:2017 + A1 2018 Clinical Accuracy Study

Baxter Healthcare Corporation·interventional·Posted Sep 28, 2023·Updated Mar 11, 2026

In Brief

A clinical study evaluating Connex CVSM with Timmy3 module for Febrile Illness. Completed, enrolled 373 participants across 5 sites.

Detailed Summary

The purpose of this document is to validate the clinical accuracy of the TIMMY3 thermometry module, integrated into host device CVSM, according to ISO 80601-2-56:2017 + A1 2018.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsFebrile Illness
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
202420252026
First PostedSep 28, 2023
Enrollment StartFeb 19, 2024
Primary CompletionMar 18, 2025
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 2.8 years ago

Interventions

Connex CVSM with Timmy3 moduledevice

Connex Vital Signs Monitor with the Timmy3 Investigational module